Necrolytic migratory erythema (glucagenoma)-like skin lesions induced by EGF-receptor inhibition.
Trojan
A
A
Department of Internal Medicine, Universitätsspital, Zurich. andreas.trojan@usz.ch
Jacky
E
E
Follath
F
F
Dummer
R
R
D002289:Carcinoma, Non-Small-Cell Lung / Q000150:complications; D004815:Epidermal Growth Factor / Q000037:antagonists & inhibitors*; D004890:Erythema / Q000139:chemically induced* / Q000473:pathology; D005260:Female; D000077156:Gefitinib; D006801:Humans; D008175:Lung Neoplasms / Q000150:complications; D008875:Middle Aged; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors*; D011799:Quinazolines / Q000009:adverse effects*
D011799:Quinazolines; D004815:Epidermal Growth Factor; D011505:Protein-Tyrosine Kinases; D000077156:Gefitinib